Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1003

2.

Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection.

Aukrust P, Hestdal K, Lien E, Bjerkeli V, Nordøy I, Espevik T, Müller F, Frøland SS.

J Infect Dis. 1997 Oct;176(4):913-23.

PMID:
9333149
4.

Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.

Rizzardi GP, Barcellini W, Tambussi G, Lillo F, Malnati M, Perrin L, Lazzarin A.

AIDS. 1996 Nov;10(13):F45-50.

PMID:
8931778
5.

Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.

Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF.

Clin Immunol. 2001 Feb;98(2):212-9.

PMID:
11161977
6.

Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell line.

Barcellini W, Rizzardi GP, Marriott JB, Fain C, Shattock RJ, Meroni PL, Poli G, Dalgleish AG.

AIDS. 1996 Jul;10(8):835-42.

PMID:
8828740
7.
8.

Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis.

Kieszko R, Krawczyk P, Chocholska S, Bojarska-Junak A, Jankowska O, Król A, Roliński J, Milanowski J.

Respir Med. 2007 Mar;101(3):645-54. Epub 2006 Aug 4.

9.

Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.

Ostrowski SR, Katzenstein TL, Pedersen BK, Gerstoft J, Ullum H.

Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.

10.

Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS.

Sippy BD, Hofman FM, Wallach D, Hinton DR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):511-21.

PMID:
8548330
11.

Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.

Zangerle R, Steinhuber S, Sarcletti M, Dierich MP, Wachter H, Fuchs D, Möst J.

Int Arch Allergy Immunol. 1998 Jul;116(3):228-39.

PMID:
9693271
12.

Tumor necrosis factor receptor p55 mediates induction of HIV type 1 expression in chronically infected U1 cells.

Edfjäll C, Jacobsen H, Lötscher H, Mous J.

AIDS Res Hum Retroviruses. 1996 Feb 10;12(3):199-204.

PMID:
8835197
13.

Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection.

Zangerle R, Gallati H, Sarcletti M, Wachter H, Fuchs D.

Immunol Lett. 1994 Jul;41(2-3):229-34.

PMID:
8002043
14.

Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infection.

Frissen PH, Weverling GJ, Endert E, Jansen J, Sauerwein HP, Lange JM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 15;12(5):482-8.

PMID:
8757425
15.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
16.

A membrane TNF-alpha/TNFR ratio correlates to MODS score and mortality.

Pellegrini JD, Puyana JC, Lapchak PH, Kodys K, Miller-Graziano CL.

Shock. 1996 Dec;6(6):389-96.

PMID:
8961387
17.

Lymphocyte protein synthesis is increased with the progression of HIV-associated disease to AIDS.

Caso G, Garlick PJ, Gelato MC, McNurlan MA.

Clin Sci (Lond). 2001 Dec;101(6):583-9.

PMID:
11724643

Supplemental Content

Support Center